Protective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel disease

Table 1 Patient and hospital characteristics (n = 374744), n (%)

Variable	No drug therapy	Antiplatelet therapy	Anticoagulant therapy	Antiplatelet and anticoagulant therapy	P value
Female	53.9	52.06	52.73	43.28	< 0.001
Male	46.1	47.94	47.27	56.72	< 0.001
Mean age in years	44.02	65.55	58.8	67.97	< 0.001
Insurance provider					< 0.001
Medicare	23.61	63.1	53.73	72.47
Medicaid	20.27	7.6	13.19	8.67
Private	50.01	27.9	30.94	17.09
Uninsured	6.11	1.41	02.14	0.77
Charlson comorbidity index					< 0.001
0	69.24	29.97	41.47	17.16
1	18.68	26.87	22.51	24.13
2	6.36	18.62	15.82	20.9
3 or more	5.72	24.54	20.19	37.81
Median income in patients zip code					< 0.0178
$1-51999	25.8	25.15	23.8	22.65
$52000-65999	25.1	27.3	25.85	30.79
$66000-87999	25.73	25.18	26.59	23.92
$88000+	23.38	22.37	23.76	22.65
Hospital region					< 0.001
Northwest	21.42	19.89	22.13	19.65
Midwest	23.93	27.93	28.43	29.35
South	38.18	36.47	32.84	37.56
West	16.46	15.7	16.6	13.43
Hospital teaching status					0.0001
Non-teaching	26.15	29.81	26.27	25.37
Teaching	73.85	70.19	73.73	74.63
Hospital bed size					0.0224
Small	19.27	21.22	19.3	22.39
Medium	27.89	27.24	28.67	31.59
Large	52.84	51.54	52.03	46.02
Race					< 0.001
White	72.46	82.39	79.82	84.62
Black	14.39	9.66	11.89	10.77
Hispanic	08.42	4.33	5.23	2.82
Asian or Pacific Islander	1.5	1.12	0.96	1.03
Native American	0.39	0.52	0.2	0.26
Other	2.85	1.99	1.91	0.51
Hospital location					< 0.001
Rural	6.7	8.91	6.73	9.7
Urban	93.3	91.09	93.27	90.3